HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Pathstone Holdings LLC

Pathstone Holdings LLC trimmed its position in HealthEquity, Inc. (NASDAQ:HQY) by 24.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 16,778 shares of the company’s stock after selling 5,460 shares during the quarter. Pathstone Holdings LLC’s holdings in HealthEquity were worth $1,373,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. Clearbridge Investments LLC grew its holdings in shares of HealthEquity by 1.9% during the 2nd quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock worth $204,915,000 after purchasing an additional 43,491 shares during the period. Mackenzie Financial Corp boosted its stake in HealthEquity by 16.0% during the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock worth $203,822,000 after buying an additional 325,906 shares during the period. Dimensional Fund Advisors LP increased its position in shares of HealthEquity by 8.1% during the second quarter. Dimensional Fund Advisors LP now owns 1,547,402 shares of the company’s stock valued at $133,377,000 after acquiring an additional 115,841 shares during the last quarter. Allspring Global Investments Holdings LLC raised its stake in shares of HealthEquity by 0.8% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,122,057 shares of the company’s stock valued at $96,721,000 after acquiring an additional 9,125 shares during the period. Finally, Van Berkom & Associates Inc. lifted its holdings in shares of HealthEquity by 1.8% in the 2nd quarter. Van Berkom & Associates Inc. now owns 930,168 shares of the company’s stock worth $80,180,000 after acquiring an additional 16,807 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of HQY opened at $102.47 on Friday. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm’s fifty day simple moving average is $89.25 and its 200-day simple moving average is $82.46. The firm has a market capitalization of $8.95 billion, a price-to-earnings ratio of 85.39, a PEG ratio of 1.62 and a beta of 0.52. HealthEquity, Inc. has a twelve month low of $62.10 and a twelve month high of $105.82.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. The company had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. Equities analysts forecast that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft boosted their target price on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Barrington Research reiterated an “outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a report on Friday, September 20th. Royal Bank of Canada restated an “outperform” rating and set a $92.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. Bank of America lifted their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, JMP Securities reissued a “market outperform” rating and set a $105.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $107.23.

Insider Buying and Selling

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. This trade represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares of the company’s stock, valued at $4,540,582.62. The trade was a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 10,536 shares of company stock worth $884,517 over the last 90 days. 2.20% of the stock is owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.